Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoHealth (GOCO) Invested Capital (2019 - 2025)

GoHealth's Invested Capital history spans 7 years, with the latest figure at $574.9 million for Q3 2025.

  • For Q3 2025, Invested Capital fell 30.44% year-over-year to $574.9 million; the TTM value through Sep 2025 reached $574.9 million, down 30.44%, while the annual FY2024 figure was $729.2 million, 19.28% down from the prior year.
  • Invested Capital for Q3 2025 was $574.9 million at GoHealth, down from $839.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.8 billion in Q1 2021 and bottomed at $574.9 million in Q3 2025.
  • The 5-year median for Invested Capital is $957.0 million (2023), against an average of $1.1 billion.
  • The largest annual shift saw Invested Capital increased 23.15% in 2021 before it crashed 33.46% in 2023.
  • A 5-year view of Invested Capital shows it stood at $1.6 billion in 2021, then plummeted by 32.66% to $1.1 billion in 2022, then dropped by 14.17% to $903.4 million in 2023, then fell by 19.28% to $729.2 million in 2024, then dropped by 21.16% to $574.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Invested Capital are $574.9 million (Q3 2025), $839.1 million (Q2 2025), and $883.0 million (Q1 2025).